Jessica Holland1, Tyler Chesney1, Fahima Dossa1, Sergio Acuna1, Katherine Anne Fleshner1, Nancy N. Baxter1. 1. From the Department of Surgery, Faculty of Medicine, University of Toronto, Toronto, Ont. (Holland, Chesney, Dossa, Acuna, Fleshner, Baxter); the Department of Surgery, Li Ka Shing Knowledge Institute, St. Michael’s Hospital, Toronto, Ont. (Dossa, Acuna, Baxter); and the Institute of Health Policy, Management and Evaluation, Dalla Lana School of Public Health, University of Toronto, Toronto, Ont. (Dossa, Acuna, Baxter).
Abstract
Background: The use of prophylactic mesh in end colostomy procedures has been shown to reduce the rate of parastomal hernia. However, the degree to which the practice has been adopted clinically remains unknown. We conducted a study to evaluate the current opinions and practice patterns of Canadian and US colorectal surgeons with regard to the use of prophylactic mesh in end colostomy. Methods: Between May and July 2017, we conducted an internet-based survey of colorectal surgeons in Canada and the United States (selected at random). Using a questionnaire designed and tested for this study, we assessed the rate of mesh use, types of mesh and placement techniques, and perceived barriers and facilitators associated with the practice. Results: Forty-eight (51.6%) of 93 invited Canadian surgeons and 253 (16.6%) of 1521 invited US surgeons responded (overall response rate 18.6%). Of the 301 respondents, 32 (10.6%) were currently using mesh, 32 (10.6%) had previously used mesh, and 237 (78.7%) had never used mesh. Of 29 respondents currently using mesh, 12 (41.4%) used it only in selected patients; the majority used a sublay technique (20 [69.0%]) and biologic mesh (17 [58.6%]). Most respondents agreed that parastomal hernias are common and negatively affect quality of life; however, there remained concerns about evidence quality and the perceived risk associated with mesh among those who had never or had previously used mesh. Conclusion: Prophylactic mesh placement remains relatively uncommon; when used, biologic mesh was the most common type. Many surgeons were not convinced of the safety or efficacy of prophylactic mesh placement.
Background: The use of prophylactic mesh in end colostomy procedures has been shown to reduce the rate of parastomal hernia. However, the degree to which the practice has been adopted clinically remains unknown. We conducted a study to evaluate the current opinions and practice patterns of Canadian and US colorectal surgeons with regard to the use of prophylactic mesh in end colostomy. Methods: Between May and July 2017, we conducted an internet-based survey of colorectal surgeons in Canada and the United States (selected at random). Using a questionnaire designed and tested for this study, we assessed the rate of mesh use, types of mesh and placement techniques, and perceived barriers and facilitators associated with the practice. Results: Forty-eight (51.6%) of 93 invited Canadian surgeons and 253 (16.6%) of 1521 invited US surgeons responded (overall response rate 18.6%). Of the 301 respondents, 32 (10.6%) were currently using mesh, 32 (10.6%) had previously used mesh, and 237 (78.7%) had never used mesh. Of 29 respondents currently using mesh, 12 (41.4%) used it only in selected patients; the majority used a sublay technique (20 [69.0%]) and biologic mesh (17 [58.6%]). Most respondents agreed that parastomal hernias are common and negatively affect quality of life; however, there remained concerns about evidence quality and the perceived risk associated with mesh among those who had never or had previously used mesh. Conclusion: Prophylactic mesh placement remains relatively uncommon; when used, biologic mesh was the most common type. Many surgeons were not convinced of the safety or efficacy of prophylactic mesh placement.
Authors: Birgitta M E Hansson; Nicholas J Slater; Arjan Schouten van der Velden; Hans M M Groenewoud; Otmar R Buyne; Ignace H J T de Hingh; Rob P Bleichrodt Journal: Ann Surg Date: 2012-04 Impact factor: 12.969
Authors: Manuel López-Cano; Xavier Serra-Aracil; Laura Mora; José Luis Sánchez-García; Luis Miguel Jiménez-Gómez; Marc Martí; Francesc Vallribera; Domenico Fraccalvieri; Anna Serracant; Esther Kreisler; Sebastiano Biondo; Eloy Espín; Salvador Navarro-Soto; Manuel Armengol-Carrasco Journal: Ann Surg Date: 2016-12 Impact factor: 12.969
Authors: Sven M van Dijk; Lucas Timmermans; Eva B Deerenberg; Bas Lamme; Gert-Jan Kleinrensink; Johannes Jeekel; Johan F Lange Journal: World J Surg Date: 2015-10 Impact factor: 3.352
Authors: Mika Vierimaa; Kai Klintrup; Fausto Biancari; Mikael Victorzon; Monika Carpelan-Holmström; Jyrki Kössi; Ilmo Kellokumpu; Erkki Rauvala; Pasi Ohtonen; Jyrki Mäkelä; Tero Rautio Journal: Dis Colon Rectum Date: 2015-10 Impact factor: 4.585
Authors: Jonathan Frigault; Simon Lemieux; Dominic Breton; Philippe Bouchard; Alexandre Bouchard; Roger C Grégoire; François Letarte; Gilles Bouchard; Vincent Boun; Katia Massé; Sébastien Drolet Journal: Hernia Date: 2021-06-16 Impact factor: 4.739
Authors: Vera S Schellerer; Lenka Bartholomé; Melanie C Langheinrich; Robert Grützmann; Raymund E Horch; Susanne Merkel; Klaus Weber Journal: World J Surg Date: 2020-09-29 Impact factor: 3.352